CN103990121B - 抗原嵌合体、抗原组合物、疫苗及其制备方法和试剂盒 - Google Patents
抗原嵌合体、抗原组合物、疫苗及其制备方法和试剂盒 Download PDFInfo
- Publication number
- CN103990121B CN103990121B CN201410217707.8A CN201410217707A CN103990121B CN 103990121 B CN103990121 B CN 103990121B CN 201410217707 A CN201410217707 A CN 201410217707A CN 103990121 B CN103990121 B CN 103990121B
- Authority
- CN
- China
- Prior art keywords
- chimera
- antigen
- protein
- ctb
- renaturation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (19)
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410217707.8A CN103990121B (zh) | 2013-12-06 | 2014-05-20 | 抗原嵌合体、抗原组合物、疫苗及其制备方法和试剂盒 |
US15/102,125 US10513543B2 (en) | 2013-12-06 | 2014-07-30 | Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof |
PCT/CN2014/083291 WO2015081711A1 (zh) | 2013-12-06 | 2014-07-30 | 抗原嵌合体、抗原组合物、疫苗及其制备方法和试剂盒 |
KR1020167018064A KR101973079B1 (ko) | 2013-12-06 | 2014-07-30 | 항원 키메라, 항원 조성물, 백신, 이의 제조 방법 및 카세트 |
JP2016557173A JP6316448B2 (ja) | 2013-12-06 | 2014-07-30 | 抗原キメラ、抗原組合せ、ワクチン、それらを調製する方法、及びそれらのキット |
AU2014360050A AU2014360050B2 (en) | 2013-12-06 | 2014-07-30 | Antigen chimera, antigen combination, vaccine, method of preparing same, and kit thereof |
EP14868697.5A EP3078677B1 (en) | 2013-12-06 | 2014-07-30 | Antigen chimera, antigen combination, vaccine, method of preparing same, and kit thereof |
CA2932211A CA2932211C (en) | 2013-12-06 | 2014-07-30 | Antigen chimera, antigen composition, vaccine, method of preparing the same and cassette thereof |
BR112016012580-0A BR112016012580B1 (pt) | 2013-12-06 | 2014-07-30 | Quimera de antígeno, composição de antígeno, vacina, método de preparação da mesma e cassete da mesma |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310655338 | 2013-12-06 | ||
CN2013106553386 | 2013-12-06 | ||
CN201310655338.6 | 2013-12-06 | ||
CN201410217707.8A CN103990121B (zh) | 2013-12-06 | 2014-05-20 | 抗原嵌合体、抗原组合物、疫苗及其制备方法和试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103990121A CN103990121A (zh) | 2014-08-20 |
CN103990121B true CN103990121B (zh) | 2015-07-08 |
Family
ID=51304617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410217707.8A Active CN103990121B (zh) | 2013-12-06 | 2014-05-20 | 抗原嵌合体、抗原组合物、疫苗及其制备方法和试剂盒 |
Country Status (9)
Country | Link |
---|---|
US (1) | US10513543B2 (zh) |
EP (1) | EP3078677B1 (zh) |
JP (1) | JP6316448B2 (zh) |
KR (1) | KR101973079B1 (zh) |
CN (1) | CN103990121B (zh) |
AU (1) | AU2014360050B2 (zh) |
BR (1) | BR112016012580B1 (zh) |
CA (1) | CA2932211C (zh) |
WO (1) | WO2015081711A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104962541A (zh) * | 2015-03-31 | 2015-10-07 | 芜湖康卫生物科技有限公司 | 口服重组幽门螺杆菌疫苗的纯化工艺 |
CN105462997A (zh) * | 2015-12-23 | 2016-04-06 | 江南大学 | 一种新脲酶辅基基因及其应用 |
US20190209615A1 (en) * | 2016-09-15 | 2019-07-11 | Virex Ab | T-cell immunotherapy |
CN109010820B (zh) * | 2018-08-31 | 2021-11-02 | 中国人民解放军陆军军医大学 | 植物多糖在黏膜免疫佐剂中的用途 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005033317A1 (en) * | 2003-10-09 | 2005-04-14 | Plant Research International B.V. | Chimeric carrier molecules for the production of mucosal vaccines |
CN101036786A (zh) * | 2007-02-02 | 2007-09-19 | 中国药科大学 | 一种免佐剂具有治疗动脉粥样硬化作用的免疫调节剂 |
CN102260353A (zh) * | 2010-05-28 | 2011-11-30 | 山东先声麦得津生物制药有限公司 | 靶向性白细胞介素融合蛋白及其制备方法与应用 |
CN103127498A (zh) * | 2011-12-02 | 2013-06-05 | 上海联合赛尔生物工程有限公司 | 重组抗原组合物、疫苗、制备该抗原组合物的载体和方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4623625B2 (ja) * | 2003-07-24 | 2011-02-02 | 株式会社AMBiS | ヘテロ型5量体組換えワクチン |
CN1255542C (zh) * | 2004-03-29 | 2006-05-10 | 中国人民解放军第三军医大学 | 融合型幽门螺杆菌粘附素基因工程疫苗的制备方法 |
US20080274143A1 (en) | 2005-05-27 | 2008-11-06 | Henry Daniell | Chloroplasts Engineering to Express Pharmaceutical Proteins |
CN100460013C (zh) * | 2006-09-05 | 2009-02-11 | 重庆康卫生物科技有限公司 | 口服重组幽门螺杆菌疫苗及其制备方法 |
CN1973903A (zh) * | 2006-12-04 | 2007-06-06 | 严杰 | 预防幽门螺杆菌感染的基因重组口服疫苗及其制备方法 |
CN101062015A (zh) * | 2007-05-22 | 2007-10-31 | 中国药科大学 | 抗幽门螺杆菌感染的尿素酶表位融合肽脂质体疫苗 |
EP2397547A4 (en) | 2009-02-10 | 2012-09-05 | Univ Ryukyus | ACTIVE TRANSPORT, AS WELL AS AUXILIARY AND VACCINATE THEREOF |
CN101987873A (zh) * | 2009-08-07 | 2011-03-23 | 普罗特奥姆技术公司 | P53融合蛋白及应用 |
CN102675466A (zh) | 2011-03-09 | 2012-09-19 | 冯强 | 以大肠杆菌不耐热肠毒素b亚单位为载体的表位递送*** |
CN102151332A (zh) | 2011-03-22 | 2011-08-17 | 中国药科大学 | 一种幽门螺旋杆菌表位疫苗及其设计、制备方法和应用 |
WO2013041966A1 (en) * | 2011-09-23 | 2013-03-28 | University Of Oslo | Vaccibodies targeted to cross-presenting dendritic cells |
CN102604993B (zh) * | 2012-01-10 | 2013-03-20 | 天津耀宇生物技术有限公司 | 免疫佐剂与幽门螺杆菌抗原融合蛋白口服疫苗及其制备方法 |
-
2014
- 2014-05-20 CN CN201410217707.8A patent/CN103990121B/zh active Active
- 2014-07-30 EP EP14868697.5A patent/EP3078677B1/en active Active
- 2014-07-30 KR KR1020167018064A patent/KR101973079B1/ko active IP Right Grant
- 2014-07-30 JP JP2016557173A patent/JP6316448B2/ja active Active
- 2014-07-30 AU AU2014360050A patent/AU2014360050B2/en active Active
- 2014-07-30 CA CA2932211A patent/CA2932211C/en active Active
- 2014-07-30 WO PCT/CN2014/083291 patent/WO2015081711A1/zh active Application Filing
- 2014-07-30 BR BR112016012580-0A patent/BR112016012580B1/pt active IP Right Grant
- 2014-07-30 US US15/102,125 patent/US10513543B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005033317A1 (en) * | 2003-10-09 | 2005-04-14 | Plant Research International B.V. | Chimeric carrier molecules for the production of mucosal vaccines |
CN1890374A (zh) * | 2003-10-09 | 2007-01-03 | 植物研究国际公司 | 用于制备粘膜疫苗的嵌合载体分子 |
CN101036786A (zh) * | 2007-02-02 | 2007-09-19 | 中国药科大学 | 一种免佐剂具有治疗动脉粥样硬化作用的免疫调节剂 |
CN102260353A (zh) * | 2010-05-28 | 2011-11-30 | 山东先声麦得津生物制药有限公司 | 靶向性白细胞介素融合蛋白及其制备方法与应用 |
CN103127498A (zh) * | 2011-12-02 | 2013-06-05 | 上海联合赛尔生物工程有限公司 | 重组抗原组合物、疫苗、制备该抗原组合物的载体和方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2014360050A1 (en) | 2016-07-07 |
US20160368951A1 (en) | 2016-12-22 |
JP2017504655A (ja) | 2017-02-09 |
JP6316448B2 (ja) | 2018-04-25 |
KR20160093719A (ko) | 2016-08-08 |
KR101973079B1 (ko) | 2019-04-26 |
CA2932211C (en) | 2019-08-27 |
EP3078677B1 (en) | 2022-04-06 |
CN103990121A (zh) | 2014-08-20 |
WO2015081711A1 (zh) | 2015-06-11 |
US10513543B2 (en) | 2019-12-24 |
EP3078677A4 (en) | 2017-10-18 |
CA2932211A1 (en) | 2015-06-11 |
AU2014360050B2 (en) | 2017-11-02 |
BR112016012580A2 (pt) | 2017-09-26 |
BR112016012580B1 (pt) | 2020-12-15 |
EP3078677A1 (en) | 2016-10-12 |
BR112016012580A8 (pt) | 2018-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Medina et al. | Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice | |
CN103990121B (zh) | 抗原嵌合体、抗原组合物、疫苗及其制备方法和试剂盒 | |
EP0413378B1 (en) | Escherichia coli vaccine | |
CN104593397A (zh) | 一种优化的产肠毒素性大肠杆菌多价抗原基因序列及其在预防断奶仔猪腹泻中的应用 | |
CN105949287B (zh) | 一种a型副鸡禽杆菌免疫保护性抗原及其应用 | |
CN107529534B (zh) | 一种副鸡禽杆菌的保护性抗原、及其表达和应用 | |
KR101600959B1 (ko) | 가금 레오바이러스 시그마 c 단백질의 항원 결정기를 포함하는 재조합 단백질 및 이에 대한 항체 | |
ES2824402T3 (es) | Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas | |
CN108774628B (zh) | 合成致新生儿脑膜炎大肠杆菌糖蛋白结合疫苗的大肠杆菌工程菌及用途 | |
CN102732473B (zh) | 表达猪肺炎支原体p46蛋白的重组猪霍乱沙门氏菌及制备方法与应用 | |
CN103275228A (zh) | K99-987p-f41重组蛋白及其应用 | |
Lee et al. | Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii | |
CN104093419B (zh) | 预防禽类大肠杆菌病的广谱菌苗的制备方法 | |
CN103127498A (zh) | 重组抗原组合物、疫苗、制备该抗原组合物的载体和方法 | |
Monreal-Escalante et al. | Alfalfa plants (Medicago sativa L.) expressing the 85B (MAP1609c) antigen of Mycobacterium avium subsp. paratuberculosis elicit long-lasting immunity in mice | |
CN113754782A (zh) | 一种幽门螺旋杆菌卵黄抗体及其制备方法和应用 | |
CN103421733B (zh) | 一种副猪嗜血杆菌-猪霍乱沙门氏菌二联基因工程苗 | |
CN102676570B (zh) | 一种重组枯草芽孢杆菌免疫球蛋白结合蛋白功能域表达载体及其应用 | |
CN105713096B (zh) | 一种预防金黄色葡萄球菌感染的att融合蛋白的制备及应用 | |
CN101991864B (zh) | 一种问号钩端螺旋体dna疫苗及其构建方法和应用 | |
CN117003888B (zh) | 一种产肠毒素大肠杆菌抗原多表位融合蛋白及其制备方法和应用 | |
Saberi et al. | Production of Chimeric Tir-intimin Protein from E. coli O157: H7 in the Tobacco (Nicotiana tobbacum) Plant and its Immunological Evaluation in an Animal Model | |
CN102688502A (zh) | 一种含幽门螺杆菌UreB、CagA蛋白的基因疫苗的制备方法 | |
RU2429292C1 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДА pAg85A-CBD, ШТАММ Escherichia coli [pREP4, pAg85A-CBD], ХИМЕРНЫЙ БЕЛОК Ag85A-CBD И ИХ ПРИМЕНЕНИЕ | |
Singh et al. | Production, Purification and Characterization of Chicken Egg Yolk Monoclonal Antibody Against Colonization factor antigen-1 of Enterotoxigenic Escherichia coli Causing Diarrhea |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Antigen chimera, antigen composition, vaccine and its preparation method and kit Effective date of registration: 20220629 Granted publication date: 20150708 Pledgee: China Minsheng Banking Corp Shanghai branch Pledgor: SHANGHAI UNITED CELL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022310000101 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230828 Granted publication date: 20150708 Pledgee: China Minsheng Banking Corp Shanghai branch Pledgor: SHANGHAI UNITED CELL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2022310000101 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Antigen chimeras, antigen compositions, vaccines, and their preparation methods and kits Effective date of registration: 20230829 Granted publication date: 20150708 Pledgee: China Minsheng Banking Corp Shanghai branch Pledgor: SHANGHAI UNITED CELL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2023310000493 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |